安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMGN 安进

交易中 02-13 10:06:16 EST

366.26

+2.58

+0.71%

最高368.00	最低361.71	成交量24.69万
今开362.10	昨收363.68	日振幅1.73%
总市值1,972亿	流通市值1,967亿	总股本5.38亿
成交额9,015万	换手率0.05%	流通股本5.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":366.26,"timestamp":1770995176421,"preClose":363.68,"halted":0,"volume":246925,"delay":0,"changeRate":0.007094148702155697,"floatShares":536994627,"shares":538480671,"eps":14.23,"marketStatus":"交易中","change":2.58,"latestTime":"02-13 10:06:16 EST","open":362.1,"high":368,"low":361.71,"amount":90145156.67500001,"amplitude":0.017295,"askPrice":366.68,"askSize":40,"bidPrice":365.91,"bidSize":32,"shortable":3,"etf":0,"ttmEps":14.23,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771016400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":363.68,"dividendRate":0.025996,"preHourTrading":{"tag":"盘前","latestPrice":361.99,"preClose":363.68,"latestTime":"09:29 EST","volume":1745,"amount":633869.5399,"timestamp":1770992999999,"change":-1.69,"changeRate":-0.004647,"amplitude":0.011659},"postHourTrading":{"tag":"盘后","latestPrice":366.4,"preClose":366.2,"latestTime":"19:59 EST","volume":142090,"amount":52035450.6489,"timestamp":1770944373200,"change":0.2,"changeRate":0.000546,"amplitude":0.004915},"volumeRatio":0.844406,"impliedVol":0.2655,"impliedVolPercentile":0.3347},"requestUrl":"/m/hq/s/AMGN/tweets","defaultTab":"tweets","newsList":[{"id":"2610684644","title":"Argus上调安进目标价至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610684644","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610684644?lang=zh_cn&edition=full","pubTime":"2026-02-09 15:22","pubTimestamp":1770621743,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00BJJMRZ35.SGD","LU1057294990.SGD","LU2242646821.SGD","BK4581","LU1983299246.USD","LU0109394709.USD","IE00BJT1NW94.SGD","BK4533","BK4588","LU0889565916.HKD","LU0289739699.SGD","IE00B4R5TH58.HKD","BK4139","LU0868494617.USD","BK4599","BK4534","LU1023059063.AUD","AMGN","IE00B2B36J28.USD","LU0122379950.USD","LU1571399168.USD","SG9999001440.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU2242652126.USD","IE0002141913.USD","LU2112291526.USD","BK4566","IE0009355771.USD","BK4585","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2609324007","title":"花旗上调安进目标价至345美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609324007","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609324007?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:27","pubTimestamp":1770280021,"startTime":"0","endTime":"0","summary":"花旗将安进的目标价从315美元上调至345美元，维持“中性”评级。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260205/32000802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["AMGN"],"gpt_icon":0},{"id":"1129271059","title":"安进核心业务强劲增长，抵消减肥药上市延迟影响——市场快评","url":"https://stock-news.laohu8.com/highlight/detail?id=1129271059","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129271059?lang=zh_cn&edition=full","pubTime":"2026-02-05 03:58","pubTimestamp":1770235106,"startTime":"0","endTime":"0","summary":"尽管安进公司的新型减肥药物尚需进一步测试，但其核心产品正持续推动业绩增长。威廉·布莱尔分析师指出，虽然投资者目光聚焦于减肥疗法MariTide，但该药关键的第三阶段试验结果预计要到2027年才能揭晓。在此期间，降胆固醇药物瑞百安与哮喘治疗药Tezspire等核心产品正为短期增长提供动力。\n值得注意的是，安进发布的2026年初步营收指引超出市场预期，彰显出现有产品组合的强劲实力。尽管肥胖治疗领域竞争激烈，威廉·布莱尔仍维持\"跑赢大盘\"评级，认为该股未来仍存重要临床催化剂。当前安进股价涨幅达8.5%。\n（本文根据市场公开信息整理，不构成投资建议）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","BK4533","BK4566","SG9999001440.SGD","BK4585","LU0289739699.SGD","LU0109394709.USD","LU0868494617.USD","LU0889565916.HKD","BK4599","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","AMGN","LU2242652126.USD","IE00B2B36J28.USD","LU2089984988.USD","BK4534","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1023059063.AUD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","LU1057294990.SGD","LU0122379950.USD","BK4588","IE0009355771.USD","LU1061106388.HKD","LU1983299246.USD","BK4581","LU0058720904.USD","IE00B4R5TH58.HKD","BK4139"],"gpt_icon":0},{"id":"2608239559","title":"美股异动丨安进涨超5%创新高，Q4业绩及今年指引均超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2608239559","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608239559?lang=zh_cn&edition=full","pubTime":"2026-02-04 23:30","pubTimestamp":1770219008,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4139","BK4550","LU1023059063.AUD","LU0320765992.SGD","BK4566","BK4599","LU1061106388.HKD","LU0868494617.USD","UWM","IE0009355771.USD","LU0109394709.USD","IE0002141913.USD","LU2242652126.USD","MNQmain","IE00B2B36J28.USD","SG9999001440.SGD","LU2112291526.USD","RWM","LU0058720904.USD","TNA","LU0889565916.HKD","SRTY","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","BK4581","AMGN","04332","BK4535","IE00BFTCPJ56.SGD","TWM","LU1571399168.USD","LU1983299246.USD","BK4534","LU0289739699.SGD","LU1057294990.SGD","TZA","IE00B4R5TH58.HKD","LU0122379950.USD","IWO","BK4533","BK4588","BK4585","LU2468319806.SGD","IWN","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"1165129857","title":"异动解读 | 安进盘中大涨5.30%，2026年盈利预测乐观及业绩超预期提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1165129857","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165129857?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:52","pubTimestamp":1770216769,"startTime":"0","endTime":"0","summary":"安进今日盘中大涨5.30%，引起了市场的广泛关注。消息面上，安进公司发布了乐观的2026年盈利预测，其预计年度调整后每股收益介于21.60美元至23美元之间，高于分析师平均预期的22.09美元。在此利好消息推动下，多家券商纷纷上调了安进的目标价，包括Leerink Partners将目标价从305美元上调至355美元，TD Cowen将目标价从389美元上调至420美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AMGN"],"gpt_icon":0},{"id":"2608633846","title":"安进Q4业绩超预期，继续推进新一代减肥药临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2608633846","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608633846?lang=zh_cn&edition=full","pubTime":"2026-02-04 10:18","pubTimestamp":1770171504,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1057294990.SGD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4585","LU1023059063.AUD","BK4599","LU0289739699.SGD","LU1983299246.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4581","LU2112291526.USD","BK4534","IE0009355771.USD","BK4533","LU2242652126.USD","BK4566","BK4588","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE00B2B36J28.USD","AMGN","LU0109394709.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","LU0058720904.USD","LU2242646821.SGD","IE0002141913.USD","BK4139","LU1571399168.USD","SG9999001440.SGD","LU2468319806.SGD","LU0868494617.USD"],"gpt_icon":0},{"id":"2608789416","title":"数十亿打水漂，安进退货自免 FIC 单抗","url":"https://stock-news.laohu8.com/highlight/detail?id=2608789416","media":"药研界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608789416?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:10","pubTimestamp":1770023451,"startTime":"0","endTime":"0","summary":"近日，在支付了 4 亿美元首付款后，安进终止了与协和麒麟就Rocatinlimab 达成的合作。根据 Insight 数据库，Rocatinlimab 共启动了9 项 III 期临床，其中 8 项的适应症都为特应性皮炎。2025 年11 月，《The Lancet》杂志发表了该产品用于中重度特应性皮炎的两项III 期ROCKET-IGNITE 和 ROCKET-HORIZON 研究结果。这两项研究共纳入近 1500 名受试者。安全性方面，Rocatinlimab 组与安慰剂组治疗期间不良事件发生率总体相近，前者最常见的不良事件包括发热、寒战和口腔溃疡。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202175112a6c9d457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202175112a6c9d457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU1061106388.HKD","LU2242646821.SGD","LU1571399168.USD","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","LU1057294990.SGD","IE0009355771.USD","LU0109394709.USD","BK4581","LU0868494617.USD","LU1023059063.AUD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","AMGN","BK4585","LU1983299246.USD","BK4534","BK4599","BK4139","IE0002141913.USD","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","SG9999001440.SGD","LU2089984988.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU2242652126.USD"],"gpt_icon":0},{"id":"2607090010","title":"奥本海默上调安进目标价至400美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090010","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607090010?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:55","pubTimestamp":1769763325,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","LU0868494617.USD","LU0122379950.USD","BK4588","LU0320765992.SGD","LU1057294990.SGD","BK4599","LU2242646821.SGD","BK4534","LU2089984988.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","BK4585","IE0009355771.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU2112291526.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","LU0058720904.USD","IE0002141913.USD","IE00BJT1NW94.SGD","BK4566","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU2242652126.USD","LU1571399168.USD","LU2468319806.SGD","LU0889565916.HKD","BK4139","BK4533","AMGN","LU1061106388.HKD"],"gpt_icon":0},{"id":"2606728962","title":"瑞银上调安进目标价至390美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606728962","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606728962?lang=zh_cn&edition=full","pubTime":"2026-01-27 12:27","pubTimestamp":1769488022,"startTime":"0","endTime":"0","summary":"瑞银将安进的目标价从380美元上调至390美元，维持“买入”评级。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260127/31975225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["AMGN"],"gpt_icon":0},{"id":"1172625763","title":"减肥药进入“长期维持+低频注射”时代，安进“月服”优势引领千亿美元市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1172625763","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172625763?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:12","pubTimestamp":1768374763,"startTime":"0","endTime":"0","summary":"高盛认为在“下一代减肥药物” MariTide相关的重大催化之下，安进有望踏上价值重估轨迹，其股价上行空间相比于同行可能更加广阔。全球肥胖率持续上升，肥胖被认为是重大慢性疾病风险因素，导致对有效减重治疗的巨大需求持续扩大。随着价格下降和医保覆盖扩大，患者用药意愿和人数预计大幅提升，这将推动市场规模增长。","market":"us","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1392679.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"减肥药进入“长期维持+低频注射”时代，安进“月服”优势引领千亿美元市场","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4566","LU1061106388.HKD","LU2242646821.SGD","LU1571399168.USD","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","LU1057294990.SGD","IE0009355771.USD","LU0109394709.USD","BK4581","LU0868494617.USD","LU1023059063.AUD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","AMGN","BK4585","LU1983299246.USD","BK4534","BK4599","BK4139","IE0002141913.USD","LU0289739699.SGD","LU0889565916.HKD","LU0122379950.USD","SG9999001440.SGD","LU2089984988.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU2242652126.USD"],"gpt_icon":0},{"id":"2603674356","title":"减肥药进入“长期维持+低频注射”时代 安进(AMGN.US)“月服”优势引领千亿美元市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2603674356","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603674356?lang=zh_cn&edition=full","pubTime":"2026-01-14 14:57","pubTimestamp":1768373853,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国大型制药/生物科技巨头安进公司当地时间周一透露，其试验性的减肥药——即有着“下一代减肥药”称号的GLP-1相关联药物MariTide的一项最新临床试验结果显示，当肥胖症患者们每月仅仅注射一次时，他们能够在两年内稳定保持体重下降趋势。随着价格下降和医保覆盖扩大，患者用药意愿和人数预计大幅提升，这将推动市场规模增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"减肥药进入“长期维持+低频注射”时代 安进(AMGN.US)“月服”优势引领千亿美元市场","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1061106388.HKD","LU0889565916.HKD","LU2089984988.USD","LU2242652126.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU0289739699.SGD","BK4139","LU2242646821.SGD","LU0122379950.USD","LU1057294990.SGD","LU1023059063.AUD","LU1571399168.USD","SG9999001440.SGD","BK4533","BK4599","BK4585","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4534","BK4581","IE0002141913.USD","AMGN","IE00B2B36J28.USD","BK4566","LU2468319806.SGD","LU0320765992.SGD","IE0009355771.USD","LU0868494617.USD","BK4588","IE00BFTCPJ56.SGD","LU0058720904.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"1148445500","title":"安进：Maritide扩展研究52周数据显示，绝大多数受试者采用较低月剂量或季度剂量后维持二期试验第一阶段减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1148445500","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148445500?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:53","pubTimestamp":1768262001,"startTime":"0","endTime":"0","summary":"安进公司最新公布的Maritide扩展研究结果显示，在为期52周的延长试验期间，绝大多数接受较低月度剂量或季度剂量给药的参与者，成功维持了在二期临床试验第一阶段所达到的体重减轻效果。这项扩展研究旨在评估不同给药方案对体重维持的长期影响，初步数据表明药物在延长用药周期后仍能保持疗效稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0002141913.USD","LU0109394709.USD","BK4599","BK4581","LU0868494617.USD","BK4533","BK4139","LU2242646821.SGD","SG9999001440.SGD","BK4585","LU0889565916.HKD","BK4534","LU2112291526.USD","IE0009355771.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0122379950.USD","IE00B2B36J28.USD","LU1571399168.USD","AMGN","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1983299246.USD","LU1061106388.HKD","BK4588","BK4566","LU2468319806.SGD","LU2089984988.USD","LU1023059063.AUD","LU2242652126.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"1117228263","title":"安进：Maritide治疗第二年耐受性良好，季度剂量方案下恶心呕吐发生率极低且无新增安全信号","url":"https://stock-news.laohu8.com/highlight/detail?id=1117228263","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117228263?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:53","pubTimestamp":1768261997,"startTime":"0","endTime":"0","summary":"安进公司最新研究数据显示，其药物Maritide在第二年治疗期间展现出优异的耐受性特征。值得注意的是，即便是采用季度给药方案，患者的不良反应发生率仍维持在极低水平。\n临床观察表明，治疗组恶心和呕吐等胃肠道不良事件的发生率显著偏低。更关键的是，在整个第二年研究周期内，未监测到任何新的安全性信号，这进一步印证了该疗法的可靠性和安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","BK4533","BK4566","SG9999001440.SGD","BK4585","LU0289739699.SGD","LU0109394709.USD","LU0868494617.USD","LU0889565916.HKD","BK4599","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU2468319806.SGD","AMGN","LU2242652126.USD","IE00B2B36J28.USD","LU2089984988.USD","BK4534","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1023059063.AUD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","LU1057294990.SGD","LU0122379950.USD","BK4588","IE0009355771.USD","LU1061106388.HKD","LU1983299246.USD","BK4581","LU0058720904.USD","IE00B4R5TH58.HKD","BK4139"],"gpt_icon":0},{"id":"1139121916","title":"安进：每月注射马利肽的24周研究显示2型糖尿病患者糖化血红蛋白与体重均现强劲且具临床意义的下降","url":"https://stock-news.laohu8.com/highlight/detail?id=1139121916","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139121916?lang=zh_cn&edition=full","pubTime":"2026-01-13 07:50","pubTimestamp":1768261815,"startTime":"0","endTime":"0","summary":"安进公司公布的一项为期24周的研究结果显示，在2型糖尿病患者中，每月注射一次马利肽（Maritide）能够显著且具有临床意义地降低患者的糖化血红蛋白（HbA1c）水平和体重。该研究数据展现出积极的治疗效果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU0889565916.HKD","LU2089984988.USD","LU2242652126.USD","IE00B4R5TH58.HKD","LU1983299246.USD","LU0289739699.SGD","BK4139","LU2242646821.SGD","LU0122379950.USD","LU1057294990.SGD","LU1023059063.AUD","LU1571399168.USD","SG9999001440.SGD","BK4533","BK4599","BK4585","LU2112291526.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4534","BK4581","IE0002141913.USD","AMGN","IE00B2B36J28.USD","BK4566","LU2468319806.SGD","LU0320765992.SGD","IE0009355771.USD","LU0868494617.USD","BK4588","IE00BFTCPJ56.SGD","LU0058720904.USD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2601235804","title":"美股异动丨减肥药概念股上涨，礼来涨超5%创新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2601235804","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601235804?lang=zh_cn&edition=full","pubTime":"2026-01-07 23:18","pubTimestamp":1767799100,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2662d3ff1dff9c19973bc9c47bc6f94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0256863811.USD","IE0005OL40V9.USD","LU0823416689.USD","LU2361045086.USD","LU2211815571.USD","LU2462157665.USD","LU2237443622.USD","LU0203201768.USD","LU1267930730.SGD","LU1868836757.USD","SG9999001176.SGD","LU1548497426.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","LU2471134523.USD","IE00B1BXHZ80.USD","LU0471298694.HKD","IE0002141913.USD","LU0122379950.USD","LU1127390331.HKD","BK4516","BK4007","LU2357305700.SGD","LU0256863902.USD","LU2112291526.USD","LU2361044865.SGD","LLY","LU1804176565.USD","BK4534","LU0079474960.USD","SG9999001176.USD","LU0787776722.HKD","LU0320765992.SGD","LU1093756168.USD","IE00BKPKM429.USD","LU0432979614.USD","LU1623119135.USD","LU1917777945.USD","LU0289739699.SGD","LU2491050071.SGD","IE00BK4W5L77.USD","LU0471298777.SGD","LU2168564222.USD","LU2237438978.USD","LU0234572021.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU0882574055.USD","LU1023059063.AUD","SG9999015945.SGD","LU2552382058.USD","LU2471134796.USD","LU0266013472.USD","GB00BDT5M118.USD","LU1057294990.SGD","IE00BKDWB100.SGD","LU2552382215.SGD","RHHBY","LU0097036916.USD","LU1868837136.USD","LU1868836914.USD","LU1868837300.USD","AMGN","IE0004445239.USD","LU0061475181.USD","LU1366192091.USD","LU2168564495.EUR","LU1093756325.SGD","IE00B7KXQ091.USD","LU1983299246.USD","IE00BWXC8680.SGD","BK4581","LU2746668974.SGD","BK4533","LU0094547139.USD","IE00B2B36J28.USD","LU2063271972.USD","LU0943347566.SGD","IE0009355771.USD","LU0889565916.HKD","LU0006306889.USD","LU0203202063.USD","NVO","LU0823434583.USD","LU0316494557.USD","SG9999014880.SGD","SGXZ57979304.SGD","LU0353189680.USD","LU0106261372.USD","LU2237443895.HKD","LU1988902786.USD","IE00B1XK9C88.USD","SG9999014914.USD","LU0198837287.USD","IE00BN29S564.USD","SG9999015986.USD","LU0820561909.HKD","LU1712237335.SGD","LU2265009873.SGD","SG9999013999.USD","IE00B4R5TH58.HKD","LU2461242641.AUD","IE00BJJMRZ35.SGD","SG9999018857.SGD","LU0238689110.USD","LU0320765059.SGD","LU0466842654.USD","SG9999018865.SGD","SGXZ99366536.SGD","LU2108987350.USD","IE00BJLML261.HKD","IE0004445015.USD","LU1814569148.SGD","LU2237443382.USD","LU2750360997.AUD","BK4599","LU2236285917.USD","LU0820561818.USD","SG9999017495.SGD","BK4588","LU2361044949.HKD","IE00B775H168.HKD","LU2746668461.USD","SG9999015952.SGD","LU0823434740.USD","LU2471134879.HKD","LU0385154629.USD","LU2237443549.SGD","LU1291159041.SGD","LU0683600562.USD","LU0354030438.USD","LU0109391861.USD","LU0323591593.USD","IE00BFSS8Q28.SGD","LU2360106947.USD","LU0882574139.USD","LU2471134952.CNY","LU1989771016.USD","LU1232071149.USD","LU0456855351.SGD","LU1280957306.USD","LU2324357040.USD","LU0353189763.USD","LU1069344957.HKD","LU2602419157.SGD","SGXZ31699556.SGD","LU1035775433.USD","LU2237443465.HKD","SG9999014898.SGD","SG9999014906.USD","LU1323610961.USD","IE00BJJMRY28.SGD","LU2168563687.JPY","IE00BFSS7M15.SGD","LU1064131342.USD","LU1551013425.SGD","SGXZ81514606.USD","SGXZ51526630.SGD","LU0672654240.SGD","LU0708995401.HKD","LU2491050154.USD","LU0354030511.USD","LU0786609619.USD","04332","LU2023250504.SGD","LU2456880835.USD","LU2468319806.SGD","LU1720051108.HKD","BK4585","LU2087625088.SGD","IE00BJJMRX11.SGD","LU2417539215.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0417517546.SGD","LU0689472784.USD","LU2089984988.USD","LU2106854487.HKD","LU2237443978.SGD","LU1720051017.SGD","LU1868836591.USD","SG9999015978.USD","LU2168564065.EUR","LU1551013342.USD","LU2264538146.SGD","LU1974910355.USD","LU0109394709.USD","LU2750360641.GBP","LU0096364046.USD","IE00B4JS1V06.HKD","LU2168564149.EUR","LU2491049909.HKD","LU0114720955.EUR","LU0640476718.USD"],"gpt_icon":0},{"id":"1154969640","title":"美股减肥药概念走高！礼来涨超4%，股价创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1154969640","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154969640?lang=zh_cn&edition=full","pubTime":"2026-01-07 22:47","pubTimestamp":1767797235,"startTime":"0","endTime":"0","summary":"1月7日，美股减肥药概念走高，$礼来(LLY)$涨超4%，股价创历史新高；$安进(AMGN)$涨超3%，$诺和诺德(NVO)$、$辉瑞(PFE)$涨超1%。","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2662d3ff1dff9c19973bc9c47bc6f94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","NVO","AMGN"],"gpt_icon":0},{"id":"1171276942","title":"Disco制药公司：有望获得最高6.18亿美元潜在交易总额及销售分成","url":"https://stock-news.laohu8.com/highlight/detail?id=1171276942","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171276942?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:10","pubTimestamp":1767780610,"startTime":"0","endTime":"0","summary":"根据最新合作协议条款，生物科技企业Disco制药公司将有机会获得总额高达6.18亿美元的阶段性付款。该协议还包含未来产品销售的分成权益，标志着公司创新药物研发平台获得市场认可。此次交易涉及多个靶向疗法的开发权益，资金将分阶段与研发里程碑挂钩支付。业内观察人士指出，这种结构化合作模式既保障了初创企业的现金流，又为合作方控制了研发风险。随着基因编辑技术的快速发展，此类高价值合作正在重塑生物制药行业的创新生态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4566","IE00B2B36J28.USD","LU2242652126.USD","LU1023059063.AUD","BK4533","BK4534","LU1571399168.USD","BK4139","LU2242646821.SGD","LU2112291526.USD","IE0002141913.USD","IE0009355771.USD","LU0058720904.USD","LU0889565916.HKD","LU2468319806.SGD","SG9999001440.SGD","BK4588","LU0320765992.SGD","LU1983299246.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU2089984988.USD","BK4585","LU0109394709.USD","AMGN","LU1057294990.SGD","BK4599","BK4581","LU0868494617.USD"],"gpt_icon":0},{"id":"1196601499","title":"Disco Pharmaceuticals与安进达成许可协议 共同推进新型癌症表面组靶向疗法研发","url":"https://stock-news.laohu8.com/highlight/detail?id=1196601499","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196601499?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:09","pubTimestamp":1767780543,"startTime":"0","endTime":"0","summary":"生物技术公司Disco Pharmaceuticals近日宣布与全球生物制药巨头安进（Amgen）签署一项重要许可协议。该合作旨在加速开发针对癌症表面组的新型靶向疗法，通过整合双方在肿瘤免疫学和药物研发领域的专长，探索创新治疗途径。此次合作有望为癌症患者带来更精准、有效的治疗方案，标志着表面组学研究在临床转化领域迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","IE00B4R5TH58.HKD","BK4139","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4566","AMGN","BK4599","LU2468319806.SGD","BK4585","LU1571399168.USD","SG9999001440.SGD","BK4588","LU1983299246.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4581","LU0122379950.USD","LU1061106388.HKD","LU2242652126.USD","LU2089984988.USD","BK4533","IE00B2B36J28.USD","LU2112291526.USD","IE0009355771.USD","LU0889565916.HKD","BK4534","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","LU0868494617.USD","LU2242646821.SGD","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2601822994","title":"瑞银看高安进(AMGN.US)至380美元：两款在研药物有望驱动增长至2030年","url":"https://stock-news.laohu8.com/highlight/detail?id=2601822994","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601822994?lang=zh_cn&edition=full","pubTime":"2026-01-07 14:56","pubTimestamp":1767768985,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银将其对美国生物科技巨头安进的股票评级由“中性”上调至“买入”，目标价由317美元上调至380美元，称其两款处于研发后期的产品——减肥药MariTide和心血管药物olpasiran——将驱动公司增长至2030年。这一目标价较安进周二美股收盘价有近15%的上行空间。数据显示，未合并2型糖尿病的肥胖/超重患者通过该药物治疗52周后，平均减重达20%，且未出现减重平台期;合并2型糖尿病的患者平均减重17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389753.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞银看高安进(AMGN.US)至380美元：两款在研药物有望驱动增长至2030年","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1983299246.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4599","LU0320765992.SGD","LU0109394709.USD","LU0868494617.USD","AMGN","LU2089984988.USD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","BK4581","LU1061106388.HKD","LU2242652126.USD","IE00B2B36J28.USD","BK4534","LU1571399168.USD","BK4585","IE0009355771.USD","LU0058720904.USD","BK4566","BK4139","BK4533","LU2468319806.SGD","LU2242646821.SGD","IE0002141913.USD","BK4588","IE00BJT1NW94.SGD","LU0122379950.USD"],"gpt_icon":0},{"id":"2595440607","title":"Argus上调安进目标价至360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595440607","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595440607?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:22","pubTimestamp":1767147767,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AMGN","BK4139","LU1983299246.USD","LU0058720904.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0320765992.SGD","LU1023059063.AUD","BK4599","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1057294990.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2242646821.SGD","LU0122379950.USD","BK4588","BK4533","LU0868494617.USD","BK4581","LU0109394709.USD","LU2468319806.SGD","SG9999001440.SGD","BK4534","LU2242652126.USD","LU2089984988.USD","IE00BJT1NW94.SGD","BK4585","LU1571399168.USD","LU2112291526.USD","BK4566"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.0044},{"period":"1month","weight":0.1292},{"period":"3month","weight":0.0875},{"period":"6month","weight":0.2352},{"period":"1year","weight":0.2411},{"period":"ytd","weight":0.1188}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amgen Inc是一家生物技术公司。该公司从事发现、开发、生产和提供治疗最棘手疾病的药物。该公司专注于医疗需求尚未得到满足的领域，并利用专业知识努力寻求改善人们生活的解决方案。该公司在人类治疗领域开展业务。该公司的营销产品组合包括EPOGEN（阿法依泊汀）、Aranesp（阿法达贝泊汀）、Parsabiv（etelcalcetide）、Neulasta（培非格司亭）；KANJINTI（曲妥珠单抗）、Otezla、BLINCYTO（blinatumomab）、ACTIMMUNE（干扰素γ-1b）、Neulasta（培非格司亭）、Sensipar/Mimpara（西那卡塞）、Prolia（地舒单抗）、ENBREL、QUINSAIR（左氧氟沙星）、Repatha（依洛尤单抗）等。该公司在美国和加拿大销售肿瘤坏死因子阻断剂ENBREL。该公司在全球许多国家销售抑制磷酸二酯酶4的小分子药物Otezla。该公司在全球许多国家销售前蛋白转化酶枯草溶菌素/kexin 9型 (PCSK9) 抑制剂Repatha。","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.034336},{"month":2,"riseRate":0.488372,"avgChangeRate":0.000526},{"month":3,"riseRate":0.52381,"avgChangeRate":0.019224},{"month":4,"riseRate":0.452381,"avgChangeRate":-0.002852},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.021538},{"month":11,"riseRate":0.627907,"avgChangeRate":0.022348},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045446}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}